Founded in 2008, Samumed has spent most of its lifetime working under the radar. It came out of the shadows in 2016 with a war chest of $220 million drawn from investors including Ikea’s private venture arm and some very wealthy individuals along with a pipeline of drugs it says can reverse aging.
In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital
By Michael Tattory|
2019-08-15T14:07:52-04:00
August 15th, 2019|News|Comments Off on In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital